Additionally, findings from the LAMP study suggested a decrease in ACD among individuals using atropine eye drops of varying concentrations, although these changes did not reach statistical significance [ 36 ].
← all excerpts
Efficacy and Safety of 0.03% Atropine Eye Drops in Controlling Myopia Progression: A One-Year Prospective Clinical Study.
1
—
—